Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women
Completed · Phase 1
Conditions studied: Healthy
In brief
The primary objective is to determine the effect of a high-fat meal on the bioavailability and PK of a single, oral dose of BZA/CE (PNP) 20mg/0.625 strength tablet, assessing both the BZA and CE components.
Key facts
- Study ID
- NCT00465075
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 24
- Starts
- 2007-03-01
- Expected to finish
- 2007-04-01
- Last updated by the study team
- 2007-12-28
Who can join
Age: 35 and older, up to 70. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy as determined by the investigator on the basis of history, physical examinations, clinical laboratory test results, vital signs, and 12-lead ECGs.
Where it is running
- Study site — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.